MA34964B1 - Dérivés de pipéridine pontés - Google Patents

Dérivés de pipéridine pontés

Info

Publication number
MA34964B1
MA34964B1 MA36238A MA36238A MA34964B1 MA 34964 B1 MA34964 B1 MA 34964B1 MA 36238 A MA36238 A MA 36238A MA 36238 A MA36238 A MA 36238A MA 34964 B1 MA34964 B1 MA 34964B1
Authority
MA
Morocco
Prior art keywords
piperidine derivatives
heteroatoms selected
membered
heteroaryl
heteroaryl group
Prior art date
Application number
MA36238A
Other languages
English (en)
Inventor
Karlheinz Baumann
Luke Green
Anja Limberg
Thomas Luebbers
Andrew Thomas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA34964B1 publication Critical patent/MA34964B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La présente invention porte sur des composés de formule (I), dans laquelle hétéroaryle I représente un groupe hétéroaryle à cinq ou six chaînons, contenant 1 à 3 hétéroatomes choisis entre S et N ; hétéroaryle II représente un groupe hétéroaryle à six chaînons, contenant 1 à 3 hétéroatomes choisis entre S et N, ou représente un système cyclique à deux éléments contenant 1 à 4 hétéroatomes choisis entre S et N, au moins un noyau étant aromatique par nature ; R
MA36238A 2011-03-02 2012-02-28 Dérivés de pipéridine pontés MA34964B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11156587 2011-03-02
PCT/EP2012/053301 WO2012116965A1 (fr) 2011-03-02 2012-02-28 Dérivés de pipéridine pontés

Publications (1)

Publication Number Publication Date
MA34964B1 true MA34964B1 (fr) 2014-03-01

Family

ID=45757448

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36238A MA34964B1 (fr) 2011-03-02 2012-02-28 Dérivés de pipéridine pontés

Country Status (21)

Country Link
US (1) US8703763B2 (fr)
EP (1) EP2681214B1 (fr)
JP (1) JP5753591B2 (fr)
KR (1) KR101550122B1 (fr)
CN (1) CN103403003B (fr)
BR (1) BR112013021924A2 (fr)
CA (1) CA2824239A1 (fr)
CL (1) CL2013002474A1 (fr)
CO (1) CO6761320A2 (fr)
CR (1) CR20130358A (fr)
EA (1) EA025035B1 (fr)
EC (1) ECSP13012858A (fr)
IL (1) IL227251A (fr)
MA (1) MA34964B1 (fr)
MX (1) MX2013009031A (fr)
MY (1) MY167264A (fr)
PE (1) PE20140250A1 (fr)
SG (1) SG193239A1 (fr)
UA (1) UA110368C2 (fr)
WO (1) WO2012116965A1 (fr)
ZA (1) ZA201305322B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5321839B2 (ja) * 2007-04-25 2013-10-23 日産化学工業株式会社 ポリイミド前駆体及びポリイミド並びに画像形成下層膜塗布液
US11090297B2 (en) 2013-06-21 2021-08-17 Prilenia Neurotherapeutics Ltd. Pridopidine for treating huntington's disease
EP3347363B1 (fr) * 2015-09-09 2020-01-01 H. Hoffnabb-La Roche Ag Dérivés de n-(3-azabicyclo[3.2.1]octan-8-yl)-8-(4-phényl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[l,5-a]pyridin-2-amine en tant que modulateurs de gamma-secretase pour le traitement de la maladie d'alzheimer
MX2018005890A (es) 2015-11-12 2018-08-15 Hoffmann La Roche Composiciones para tratar atrofia muscular espinal.
CN108137579B (zh) * 2015-12-10 2022-01-07 豪夫迈·罗氏有限公司 桥连哌啶衍生物
ES2879995T3 (es) 2015-12-10 2021-11-23 Ptc Therapeutics Inc Métodos para el tratamiento de la enfermedad de Huntington
EP3475279B1 (fr) * 2016-06-27 2021-07-14 F. Hoffmann-La Roche AG Triazolopyridines comme modulateurs de gamma-secretase
EP3484884B1 (fr) 2016-07-14 2021-01-27 Hoffmann-La Roche AG Dérivés de pyrimidine fusionnés
JP6912574B2 (ja) 2016-08-24 2021-08-04 プリレニア ニューロセラピューティクス リミテッド 機能低下を治療するためのプリドピジンの使用
AR109829A1 (es) * 2016-09-29 2019-01-30 Hoffmann La Roche Derivados de piperidina puenteados
CN109476670B (zh) * 2016-10-04 2022-06-28 豪夫迈·罗氏有限公司 二环杂芳基衍生物
JP7111704B2 (ja) * 2016-11-01 2022-08-02 エフ．ホフマン－ラ ロシュ アーゲー 二環式ヘテロアリール誘導体
WO2018087018A1 (fr) 2016-11-08 2018-05-17 F. Hoffmann-La Roche Ag Phénoxytriazoles
JP6904612B2 (ja) 2016-12-16 2021-07-21 パイプライン セラピューティクス， インコーポレイテッド 蝸牛シナプス障害を処置する方法
EA201992878A1 (ru) 2017-06-05 2020-05-08 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Соединения для лечения болезни хантингтона
MX2019015580A (es) 2017-06-28 2020-07-28 Ptc Therapeutics Inc Metodos para tratar la enfermedad de huntington.
BR112019027717A2 (pt) 2017-06-28 2020-07-28 Ptc Therapeutics, Inc. métodos para tratar a doença de huntington
WO2019121596A1 (fr) * 2017-12-19 2019-06-27 Boehringer Ingelheim International Gmbh Triazolo pyridines utilisées en tant que modulateurs de gamma-sécrétase
EP3743428B1 (fr) 2018-01-22 2022-01-19 F. Hoffmann-La Roche AG Dérivés de triazolo-azépine
CN112135815A (zh) 2018-03-27 2020-12-25 Ptc医疗公司 用于治疗亨廷顿氏病的化合物
EP3814360A1 (fr) 2018-06-27 2021-05-05 PTC Therapeutics, Inc. Composés hétéroaryles pour le traitement de la maladie de huntington
AU2019294478B2 (en) 2018-06-27 2023-03-23 Ptc Therapeutics, Inc. Heterocyclic and heteroaryl compounds for treating Huntington's disease
PT3846903T (pt) * 2018-09-03 2023-12-14 Hoffmann La Roche Derivados heteroarílicos bicíclicos
US20220056036A1 (en) * 2018-12-13 2022-02-24 Hoffmann-La Roche Inc. 7-phenoxy-n-(3-azabicyclo[3.2.1]octan-8-yl)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,4]triazol-2-amine derivatives and related compounds as gamma-secretase modulators for the treatment of alzheimer's disease
CN113372364A (zh) * 2020-03-10 2021-09-10 明慧医药（上海）有限公司 一类jak激酶抑制剂及其制备和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432985B2 (en) * 2000-04-25 2002-08-13 Hoffmann-La Roche Inc. Neuroprotective substituted piperidine compounds with activity as NMDA NR2B subtype selective antagonists
US7037902B2 (en) 2002-07-03 2006-05-02 Receptron, Inc. Affinity small molecules for the EPO receptor
HU227684B1 (en) 2003-08-29 2011-11-28 Sanofi Aventis Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
EA014057B1 (ru) * 2005-10-06 2010-08-30 Ниппон Сода Ко., Лтд. Поперечно связанные соединения циклических аминов и средства для борьбы с вредителями
CA2713716A1 (fr) 2008-02-22 2009-08-27 F. Hoffmann-La Roche Ag Modulateurs de la beta-amyloide
US20110190269A1 (en) 2010-02-01 2011-08-04 Karlheinz Baumann Gamma secretase modulators
US8486967B2 (en) 2010-02-17 2013-07-16 Hoffmann-La Roche Inc. Heteroaryl substituted piperidines

Also Published As

Publication number Publication date
IL227251A (en) 2016-09-29
US8703763B2 (en) 2014-04-22
UA110368C2 (en) 2015-12-25
SG193239A1 (en) 2013-10-30
JP5753591B2 (ja) 2015-07-22
US20120225884A1 (en) 2012-09-06
CN103403003A (zh) 2013-11-20
EP2681214A1 (fr) 2014-01-08
AU2012222426A1 (en) 2013-07-11
MY167264A (en) 2018-08-14
PE20140250A1 (es) 2014-03-12
BR112013021924A2 (pt) 2020-10-20
KR101550122B1 (ko) 2015-09-03
CN103403003B (zh) 2016-09-14
ECSP13012858A (es) 2013-10-31
CO6761320A2 (es) 2013-09-30
KR20130140142A (ko) 2013-12-23
CR20130358A (es) 2013-10-03
EA201391209A1 (ru) 2013-12-30
CL2013002474A1 (es) 2014-05-30
EP2681214B1 (fr) 2017-03-22
IL227251A0 (en) 2013-09-30
CA2824239A1 (fr) 2012-09-07
MX2013009031A (es) 2013-09-02
NZ612525A (en) 2015-08-28
ZA201305322B (en) 2014-04-30
EA025035B1 (ru) 2016-11-30
WO2012116965A1 (fr) 2012-09-07
JP2014506903A (ja) 2014-03-20

Similar Documents

Publication Publication Date Title
MA34964B1 (fr) Dérivés de pipéridine pontés
MA38540B1 (fr) Dérivés de naphtyridine utiles comme antagonistes de l&#39;intégrine alpha-v-bêta-6
MA35172B1 (fr) Melanges pestticides contenant des derives d&#39;isoxazoline
MA37519B1 (fr) Composés et compositions pour inhiber l&#39;activité d&#39;abl1, abl2 et bcr-abl1
EA201070994A1 (ru) Конденсированное гетероциклическое производное и его применение
MA32171B1 (fr) Compose heterocyclique
MA33240B1 (fr) Inhibiteurs de bêta-sécrétase
EA201290401A1 (ru) Азотсодержащее гетероциклическое соединение и сельскохозяйственный фунгицид
MA33275B1 (fr) Inhibiteurs de la replication du virus de l&#39;immunodeficience humaine
MA34819B1 (fr) Dérivés bicyclo[3.2.1]octylamide et leurs utilisations
MA31118B1 (fr) Procede de preparation d&#39;un derive de benzimidazole
EA201491936A1 (ru) Азотсодержащее гетероциклическое соединение
UA110647C2 (uk) Похідне азолу, спосіб його одержання, проміжна сполука і хімічний агент, призначений для застосування в сільському господарстві і садівництві, і агент для захисту промислових матеріалів
MA37886B1 (fr) Nouvelles pyridinones bicycliques
MA32173B1 (fr) Derives de pyridin-2-yle utilises comme agents immunomodulateurs
MA35086B1 (fr) Compose de triazolopyridine
MA33836B1 (fr) Compositions pharmaceutiques contenant des ligands des récepteurs sigma
MA38112A1 (fr) Dérivés d&#39;imidazopyridazine en tant que modulateurs d&#39;un récepteur gabaa
MA33618B1 (fr) Agent thérapeutique destiné aux troubles de l&#39;humeur
MA30916B1 (fr) Nouveaux derives de benzamide en tant qu&#39;antagonistes de bradykinine
MA38275A1 (fr) Hétérocycles azotés saturés et n-acylés potentialisant l&#39;activité d&#39;un antibiotique actif contre les mycobactéries
MA45782B1 (fr) Modulateurs du récepteur de cxcr7 pipéridine
MA38410B1 (fr) Composés d&#39;azétidinyloxyphénylpyrrolidine
MA38010B1 (fr) Dérivés d&#39;éthynyl utilisés en tant que modulateurs de l&#39;activité des récepteurs mglur5
FR3020809B1 (fr) Derives de 4-vinyl-2cyclopentene-1-one leur preparation et leur utilisation en tant qu&#39;agent antibiotique